Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)
Citalopram Treatment in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior
Sponsor: Boston University
Listed as NCT00086645, this PHASE2 trial focuses on Autistic Disorder and remains completed. Sponsored by Boston University, it has been updated 7 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Apr 2017 — Jun 2018 [monthly]
Completed PHASE2
▶ Show 2 earlier versions
-
Feb 2017 — Apr 2017 [monthly]
Completed PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
Apr 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston University
- National Institute of Mental Health (NIMH)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Chapel Hill, United States
- • Great Neck, United States
- • Lebanon, United States
- • Los Angeles, United States
- • New Haven, United States
- • New York, United States